Pharmaceuticals

Drug regulator sounds health alert on antacid ranitidine

25 Sep 2019

Roche’s $4.3 billion takeover offer for Spark extended till 1 October

05 Sep 2019

In-vitro diagnostics firm Transasia-Erba doubles R&D spending

13 Aug 2019

Dr Reddy's Q1 net profit rises 45% to Rs662.8cr on one-off gains

30 Jul 2019

AstraZeneca and Merck claim Japanese approval for anti-cancer drug Lynparza

20 Jun 2019

Pfizer to acquire cancer drug maker Array Biopharma for $10.6 bn

18 Jun 2019

Array’s Braftovi and Mektovi, launched last July for the deadliest form of skin cancer at a price of $22,000 per month, had sales of around $72 million over their first nine months, besides revenue from royalty and licensing deals

CCI approves GSK-Pfizer consumer healthcare JV

24 May 2019

And now, formaldehyde found in J&J’s baby shampoo

01 Apr 2019

Johnson & Johnson is facing regulatory scrutiny over most of its products, including its baby care products, over health concerns

AstraZeneca in $6.9 bn deal with Daiichi Sankyo for cancer drug development

29 Mar 2019

DRDO lab develops 'combat drugs' to reduce casualties in enemy attacks

12 Mar 2019

Merck offers to buy electronic materials maker Versum for $5.9 bn

04 Mar 2019

Pharmaceutical residues in fresh water pose a growing environmental risk

25 Feb 2019

American drug overdose death rates the highest among wealthy nations: study

21 Feb 2019

Sales of Xanax and other prescription psychiatric drugs increasing via the darknet

15 Feb 2019

Sun Pharma’s Q3 net profit vaults 49% to Rs1,242 crore

13 Feb 2019

NITI Aayog delegated NPPA role of drug price regulation

24 Jan 2019

A NITI Aayog-led body will now recommend prices to the NPPA on drugs and other health products, which relegates NPPA to a mere implementing body

J&J settles US hip implant claims for $120 mn; posts higher Q4 revenues

23 Jan 2019

Pfizer to shutter two more plants in India

09 Jan 2019

Eli Lilly to acquire Loxo Oncology for $8 bn in cash

09 Jan 2019

Loxo’s oncology drug Vitrakvi, priced at $32,800 per month, and experimental follow-up drug LOXO-195, on which Bayer is also a partner, together could generate annual sales of about $750 million

Bengaluru to host pharma and medical devices conference on 18-19 Feb

07 Jan 2019

Bristol-Myers to acquire Celgene in $74-bn cash-and-stock deal

03 Jan 2019

Celgene shareholders will receive one Bristol-Myers Squibb share and $50 in cash for each share held, or $102.43 per share, a premium of 53.7 per cent to Celgene’s Wednesday close, besides one tradable contingent value right for each share held

J&J told to stop using its baby powder raw material in India

21 Dec 2018

Reports quoting an unnamed senior CDSCO official said on Thursday that Johnson & Johnson has been served with a written order to stop using the "huge quantities" of raw materials stocked in its plants in India

Indian drug regulator may revive probe to J&J’s baby powder: Reuters

18 Dec 2018

Novartis to acquire US cancer drugs maker Endocyte for $2.1 billion

19 Oct 2018

Medical stores protest plans to regularise e-pharmacies

28 Sep 2018

View details about the software product Informachine News Trackers